Atlas FDA

Toshiba Aquilion CT System TSX-303A

FDA device recall Z-0018-2016 · posted 2015-10-09 · Terminated

Recall details

Recalling firm
Toshiba American Medical Systems Inc
Reason for recall
If two specific operations are performed in multi-phase helical scanning, the acquired raw data may not be saved.
Action taken
Toshiba America Medical Planned Action to bring defect into Compliance: a. A notification will be sent to all consignees with affected systems in compliance with 21 CFR1 003.21 upon approval by the Secretary. b. To correct this issue revised software will be installed on each system to prevent this occurrence from happening. Each consignee will be contacted by their Toshiba service representative for an appointment when the revised software becomes available. c. Each consignee will be advised to do the following until the corrective measures have been taken, i.e., revised software installed on their systems. CDRH approves the CAP subject to the following conditions: 1. Notification of all dealers and purchasers is to be made within 15 working days of receipt of this letter in the manner specified in 21 CFR 1003.21 and 1003.22. This office and the Food and Drug Administration (FDA) district office coordinator noted below are to be included in the notification. 2. Toshiba America Medical Systems, Inc. will implement this CAP by February 1, 2016. If you have any questions please contact your local Toshiba Representative at (800) 521-1968.
Root cause
Radiation Control for Health and Safety Act
Status
Terminated
Product code
JAK
Quantity affected
459
Distribution
US Distribution including Puerto Rico
Date initiated
2015-05-08
Date posted
2015-10-09
Date terminated
2016-10-26
Location
Tustin, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
AQUILION PRIME, V6.00 (K141741)Toshibamedical Systems Corporation2014-11-26